Arthex Biotech Announces First Patient Dosed In Phase I-Iia Arthemirtm Trial For Myotonic Dystrophy Type 1 (DM1)

(MENAFN - PR Newswire) ARTHEx logo (PRNewsfoto/ARTHEx Biotech) -ATX-01 is the industry's first anti-microRNA therapeutic to be investigated in DM1 ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute